119 related articles for article (PubMed ID: 16425301)
1. Expression of protease activated receptor-2 (PAR-2) in gastric cancer.
Fujimoto D; Hirono Y; Goi T; Katayama K; Hirose K; Yamaguchi A
J Surg Oncol; 2006 Feb; 93(2):139-44. PubMed ID: 16425301
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1) in gastric cancer.
Fujimoto D; Hirono Y; Goi T; Katayama K; Yamaguchi A
Anticancer Res; 2008; 28(2A):847-54. PubMed ID: 18507028
[TBL] [Abstract][Full Text] [Related]
3. Protease-activated receptor-2 (PAR-2) in cervical cancer proliferation.
Sánchez-Hernández PE; Ramirez-Dueñas MG; Albarran-Somoza B; García-Iglesias T; del Toro-Arreola A; Franco-Topete R; Daneri-Navarro A
Gynecol Oncol; 2008 Jan; 108(1):19-26. PubMed ID: 17936340
[TBL] [Abstract][Full Text] [Related]
4. Expression of protease activated receptor-2 in human colorectal cancer and its association with tumor progression.
Chang JH; Park JM; Kim SW; Jung CK; Kang WK; Oh ST
Dis Colon Rectum; 2010 Aug; 53(8):1202-8. PubMed ID: 20628286
[TBL] [Abstract][Full Text] [Related]
5. Arp2/3 overexpression contributed to pathogenesis, growth and invasion of gastric carcinoma.
Zheng HC; Zheng YS; Li XH; Takahashi H; Hara T; Masuda S; Yang XH; Guan YF; Takano Y
Anticancer Res; 2008; 28(4B):2225-32. PubMed ID: 18751399
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
7. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
[TBL] [Abstract][Full Text] [Related]
8. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
[TBL] [Abstract][Full Text] [Related]
9. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer.
Chen CN; Hsieh FJ; Cheng YM; Chang KJ; Lee PH
J Surg Oncol; 2006 Sep; 94(3):226-33. PubMed ID: 16900533
[TBL] [Abstract][Full Text] [Related]
10. Urokinase system expression in gastric carcinoma: prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens.
Beyer BC; Heiss MM; Simon EH; Gruetzner KU; Babic R; Jauch KW; Schildberg FW; Allgayer H
Cancer; 2006 Mar; 106(5):1026-35. PubMed ID: 16435385
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of osteopontin expression in human gastric carcinoma.
Higashiyama M; Ito T; Tanaka E; Shimada Y
Ann Surg Oncol; 2007 Dec; 14(12):3419-27. PubMed ID: 17896150
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of lysophosphatidic acid receptor-2 in intestinal and diffuse type gastric cancer.
Yamashita H; Kitayama J; Shida D; Ishikawa M; Hama K; Aoki J; Arai H; Nagawa H
J Surg Oncol; 2006 Jan; 93(1):30-5. PubMed ID: 16353194
[TBL] [Abstract][Full Text] [Related]
13. Expression of protease-activated receptor-2 (PAR-2) in patients with nasopharyngeal carcinoma: correlation with clinicopathological features and prognosis.
Li Z; Bian LJ; Li Y; Liang YJ; Liang HZ
Pathol Res Pract; 2009; 205(8):542-50. PubMed ID: 19269113
[TBL] [Abstract][Full Text] [Related]
14. Protease-activated receptor (PAR)-1 and PAR-2 participate in the cell growth of alveolar capillary endothelium in primary lung adenocarcinomas.
Jin E; Fujiwara M; Pan X; Ghazizadeh M; Arai S; Ohaki Y; Kajiwara K; Takemura T; Kawanami O
Cancer; 2003 Feb; 97(3):703-13. PubMed ID: 12548614
[TBL] [Abstract][Full Text] [Related]
15. Expression of ERas oncogene in gastric carcinoma.
Kaizaki R; Yashiro M; Shinto O; Yasuda K; Matsuzaki T; Sawada T; Hirakawa K
Anticancer Res; 2009 Jun; 29(6):2189-93. PubMed ID: 19528480
[TBL] [Abstract][Full Text] [Related]
16. Protease-activated receptor-2 expression and the role of trypsin in cell proliferation in human pancreatic cancers.
Ohta T; Shimizu K; Yi S; Takamura H; Amaya K; Kitagawa H; Kayahara M; Ninomiya I; Fushida S; Fujimura T; Nishimura G; Miwa K
Int J Oncol; 2003 Jul; 23(1):61-6. PubMed ID: 12792776
[TBL] [Abstract][Full Text] [Related]
17. [Correlation between expression of RB protein and prognosis of gastric cancer].
Ogawa M; Maeda K; Chung YS; Onoda N; Kato Y; Nakata B; Sowa M
Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():148-50. PubMed ID: 8678558
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
Wang M; Pan JY; Song GR; Chen HB; An LJ; Qu SX
Eur J Surg Oncol; 2007 Mar; 33(2):195-201. PubMed ID: 17046193
[TBL] [Abstract][Full Text] [Related]
19. Neurotrophic receptor, tropomyosin-related kinase B as an independent prognostic marker in gastric cancer patients.
Tanaka K; Mohri Y; Nishioka J; Kobayashi M; Ohi M; Miki C; Tonouchi H; Nobori T; Kusunoki M
J Surg Oncol; 2009 Apr; 99(5):307-10. PubMed ID: 19170129
[TBL] [Abstract][Full Text] [Related]
20. Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters.
Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
J Surg Oncol; 2007 Feb; 95(2):123-8. PubMed ID: 17262742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
